HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
6 hedge funds and large institutions have $15.3M invested in Hepion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.4M | |
| 2 | +$1.26M | |
| 3 | +$744K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$416K |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$250K | |
| 3 | -$207K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$32K |
| 5 |
Barclays
London,
United Kingdom
|
-$28K |